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Ca21 Channel Subunit Isoforms a1C and a1D Does not Correlate
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ABSTRACT Ca21-induced Ca21-release (CICR)—the mechanism of cardiac excitation-contraction (EC) coupling—also
contributes to skeletal muscle contraction; however, its properties are still poorly understood. CICR in skeletal muscle can be
induced independently of direct, calcium-independent activation of sarcoplasmic reticulum Ca21 release, by reconstituting
dysgenic myotubes with the cardiac Ca21 channel a1C (CaV1.2) subunit. Ca
21 inﬂux through a1C provides the trigger for
opening the sarcoplasmic reticulum Ca21 release channels. Here we show that also the Ca21 channel a1D isoform (CaV1.3) can
restore cardiac-type EC-coupling. GFP-a1D expressed in dysgenic myotubes is correctly targeted into the triad junctions and
generates action potential-induced Ca21 transients with the same efﬁciency as GFP-a1C despite threefold smaller Ca
21
currents. In contrast, GFP-a1A, which generates large currents but is not targeted into triads, rarely restores action potential-
induced Ca21 transients. Thus, cardiac-type EC-coupling in skeletal myotubes depends primarily on the correct targeting of the
voltage-gated Ca21 channels and less on their current size. Combined patch-clamp/ﬂuo-4 Ca21 recordings revealed that the
induction of Ca21 transients and their maximal amplitudes are independent of the different current densities of GFP-a1C and
GFP-a1D. These properties of cardiac-type EC-coupling in dysgenic myotubes are consistent with a CICR mechanism under the
control of local Ca21 gradients in the triad junctions.
INTRODUCTION
Excitation-contraction (EC) coupling in muscle depends on
the close interaction of a voltage-gated Ca21 channel in the
t-tubule or the plasma membrane with a Ca21 release channel
(ryanodine receptor, RyR) in the sarcoplasmic reticulum
(SR). In cardiac EC-coupling this interaction is mediated by
Ca21 entering the cell through a voltage-gated Ca21 channel
that in turn activates Ca21 release from the SR. In skeletal
muscle, SR Ca21 release is activated in the absence of Ca21
inﬂux, presumably by a physical interaction of the two Ca21
channels. Under experimental conditions, the skeletal muscle
Ca21 release channel (RyR1) can also be activated by mM
concentrations of cytoplasmic free Ca21 (Nagasaki andKasai,
1983; Smith et al., 1986). Whether Ca21-induced Ca21-re-
lease (CICR) in skeletal muscle occurs under physiological
conditions, and if so, to what extent it contributes to skeletal
muscle EC-coupling is still not resolved.
Reconstitution of Ca21 channel null-mutant skeletal myo-
tubes with wild-type and mutant heterologous Ca21 channels
has been a potent tool for analyzing the mechanism of EC-
coupling in an intact muscle system. Normal function can
be restored in dysgenic myotubes, which lack the skeletal
muscle Ca21 channel a1S subunit, by heterologous expres-
sion of a1S (Tanabe et al., 1988). When dysgenic myotubes
are reconstituted with the cardiac Ca21 channel a1C subunit,
‘‘cardiac-type’’ EC-coupling is restored, which is character-
ized by its dependence on Ca21 inﬂux (Tanabe et al., 1990).
Presumably the skeletal muscle Ca21 release channel is acti-
vated by trigger Ca21 entering the myotube through a1C.
However, not all examined Ca21 channel isoforms that
produced Ca21 currents when expressed in dysgenic myo-
tubes also triggered CICR from the SR. The neuronal isoform
a1A, which is not targeted into triads of dysgenic myotubes,
only very rarely displayed evoked contractions (Adams et al.,
1994) or Ca21 transients in response to electrically induced
action potentials (action potential-induced Ca21 transients)
(Flucher et al., 2000). Apparently the correct subcellular
distribution of the channel is important for the activation
of cardiac-type EC-coupling in skeletal myotubes. Skeletal-
type EC-coupling properties could be conferred onto the
cardiac a1C subunit by replacing a short sequence of the
cytoplasmic loop connecting the homologous repeats II and
III with that of a1S (Nakai et al., 1998). Thus, the chimera
CSk53 was created, which combines skeletal-type activation
of EC-coupling with cardiac current properties.
If CICR participates in normal skeletal muscle EC-
coupling, it is unlikely that the trigger Ca21 comes from the
Ca21 currents across the sarcolemma, because the slow acti-
vation of the skeletal Ca21 current lags behind activation
of SR calcium release (Garcia et al., 1989; Feldmeyer et al.,
1990). Instead, trigger Ca21 must be provided by Ca21
released from the SR by the population of the skeletal muscle
RyR1 that is under the direct control of the voltage-sensor
a1S subunit (reviewed in Rios and Stern, 1997). In other
words, Ca21 released through the RyR1 provides a positive
feedback resulting in release of more Ca21 from the same
or adjacent RyRs. A recent report by O’Brien et al. (2002)
indicates that, whereas CICR appears not to be necessary for
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activation of EC-coupling in skeletal muscle, SR Ca21
release is reduced by ﬁvefold when Ca21 activation of RyR1
is impeded. This indicates a signiﬁcant contribution of CICR
to skeletal muscle EC-coupling.
Here we studied the properties of CICR in skeletal
myotubes separate from skeletal-type activation of Ca21
release by expressing nonskeletal a1 subunits with distinct
current characteristics and with distinct targeting character-
istics in dysgenic myotubes. Analyzing the capability of
different types of Ca21 channels to generate action potential-
induced and voltage-clamp-induced Ca21 transients indi-
cates that in the absence of direct skeletal coupling, Ca21
currents of similar size as those of the skeletal a1S are
sufﬁcient to trigger CICR. Moreover, the results indicate that
activation of SR Ca21 release seems to depend less on the
magnitude of the whole-cell current than on the correct
localization of the channels in the triads.
MATERIALS AND METHODS
Cell culture and transfections
Myotubes of the homozygous dysgenic (mdg/mdg) cell line GLT were
cultured as described in Powell et al. (1996). At the onset of myoblast fusion
(2 days after addition of differentiation medium), GLT cultures were
transfected using FuGene transfection reagent (Roche, Basel, Switzerland).
Cultures were analyzed 3–5 days after transfection.
a1 subunit constructs
The following GFP-tagged Ca21 channel constructs have been used: a1S,
a1A, a1C (Grabner et al., 1998), a1D (Koschak et al., 2001), and a1G (Monteil
et al., 2000). GFP-CSk53: The BamHI-EcoRV fragment (nt 1265–4351; a1C
numbering) of clone CSk53 (Nakai et al., 1998), where part of the II-III loop
coding a1C cDNA sequence (nt 2549–2690) was replaced by a1S sequence
(nt 2156–2297), was ligated into the corresponding restriction enzyme sites
of clone GFP-a1C (Grabner et al., 1998) resulting in an N-terminally GFP-
tagged CSk53.
GFP and immunoﬂuorescence labeling
Differentiated GLT cultures were ﬁxed and immunostained as previously
described (Flucher et al., 1994; Flucher et al., 2000). For double-immuno-
ﬂuorescence labeling we used an afﬁnity-puriﬁed anti-GFP antibody
(Molecular Probes, Eugene, OR) at a ﬁnal dilution of 1:4000 and the afﬁnity-
puriﬁed antibody 162 (Giannini et al., 1995) against RyR1 at a dilution of 1:
5000. Alexa-488- and Alexa-594-conjugated secondary antibodies (Molec-
ular Probes) at dilutions of 1:4000 were used to achieve a wide separation of
the ﬂuorescence signals. Alexa-488 was usually used with the anti-GFP
antibody so that the antibody label and the intrinsic GFP signal were both
recorded in the green channel. Controls, for example multiple combinations
of primary and secondary antibodies and the omission of primary antibodies,
were routinely performed.
Images of the double labeling experiments were recorded on an Axiophot
microscope (Carl Zeiss, Jena, Germany) using a cooled CCD camera and
Meta View image processing software (Universal Imaging Corporation,
West Chester, PA). Quantitative analysis of the labeling patterns was
performed by systematically screening the cover glasses for transfected
myotubes using a 633 objective. The labeling pattern in transfected
myotubes with more than two nuclei was classiﬁed as ‘‘clustered’’ when
punctuate a1 subunit ﬂuorescence was co-localized with a similar RyR1
label (Fig. 1). The counts were obtained from several samples of at least
three different experiments.
Patch-clamp and intracellular Ca21 recording
Whole-cell patch-clamp recordings were performed with an Axopatch 200A
ampliﬁer controlled by pClamp 8.0 software (Axon Instruments Inc., Union
City, CA, USA). The bath solution contained (mM): 10 CaCl2, 145
tetraethylammonium chloride, and 10 HEPES (pH 7.4 with TEA-OH). Patch
pipettes, pulled from borosilicate glass (Harvard Apparatus, Kent, UK) had
resistances of 1.8 to 2.5 MV when ﬁlled with 145 Cs-aspartate, 2 MgCl2, 10
HEPES, 0.1 Cs-EGTA, 2 Mg-ATP (pH 7.4 with Cs-OH). For simultaneous
recording of whole-cell currents and Ca21 transients the pipette solution
additionally contained 0.2 mM ﬂuo-4-K5 (Molecular Probes). The Ca
21
ﬂuorescence signal was recorded by a photometer system (PTI, S. Bruns-
wick, NJ, USA) adjusted to the Zeiss Axiovert epiﬂuorescence microscope.
Ca21 transients were normalized by the resting ﬂuorescence (DF/F). To at-
tempt block of SR Ca21 release, ryanodine and ruthenium red (both Sigma-
Aldrich, Vienna, Austria) were dissolved in absolute ethanol or water,
respectively, and added to the pipette solution at ﬁnal concentrations of 10–
40 mM for ryanodine and 10–160 mM for ruthenium red.
Leak currents were digitally subtracted by a P/4 prepulse protocol.
Recordings were low-pass Bessel ﬁltered at 1 kHz and sampled at 5 kHz.
Currents were determined with 200 ms depolarizing steps from a holding
potential of 80 mV to test potentials between 40 and180 mV in 10 mV
increments. Test pulses were preceded by a 1-s prepulse to 30 mV to
FIGURE 1 The L-type Ca21 channel subunit GFP-a1D is targeted into
skeletal muscle triads of dysgenic myotubes. Dysgenic myotubes transfected
with GFP-a1D were double immunoﬂuorescence labeled with antibodies
against GFP (top) and against the skeletal muscle RyR1 (middle). GFP-a1D is
distributed inclusters co-localizedwithRyR1(examples indicatedbyarrows),
which indicates a localization of GFP-a1D in junctions of the SR with the
plasma membrane or the t-tubules (triads). The color overlay (bottom) shows
the co-localization of GFP-a1D clusters (green) and RyR1 clusters (red ) as
yellow foci. The inset shows a fourfold enlarged area. Bar, 10 mm.
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inactivate endogenous T-type Ca21 currents (Adams et al., 1990). Current
recordings of cells transfected with the T-type Ca21 channel a1G subunit
were measured with 200 ms depolarizing steps from a holding potential
of 90 mV to test potentials between 80 mV and 180 mV in 10 mV
increments. Ca21 current densities were normalized by linear cell capaci-
tance and expressed in pA/pF.
Action potential–induced Ca21 transients were recorded in cultures
loaded for 45–60 min at room temperature with 5 mM ﬂuo-4-AM plus 0.1%
Pluronic F-127 (Molecular Probes) in HEPES and bicarbonate-buffered
DME, as previously described (Flucher et al., 1993; Powell et al., 1996).
Action potentials were elicited by passing 1 ms pulses of 30 V across the 19-
mm incubation chamber. 0.5 mM Cd21 and 0.1 mM La31 were added to
block Ca21 inﬂux and therefore allow discrimination between CICR and
skeletal-type EC coupling. Application of 6 mM caffeine to the bath solution
resulted in rapid Ca21 release and thus proved the capacity of SR Ca21
release.
Statistics
Data were expressed as mean6 SE where n is the number of cells examined.
Data analysis, unpaired Student’s t-test, and one-way-ANOVA analysis
followed by the Tukey post test were performed with Clampﬁt 8.0 (Axon
instruments, Union City, CA, USA) and GraphPad Prism software
(GraphPad Inc., San Diego, CA, USA). P\0.05 was considered statistically
signiﬁcant.
RESULTS
It has previously been demonstrated that heterologous
expression of different muscle a1 subunit isoforms in dys-
genic myotubes restores EC-coupling by two distinct mech-
anisms. Whereas the skeletal muscle a1S triggers SR Ca
21
release independently of Ca21 inﬂux through the L-type
Ca21 channel, the cardiac a1C depends on Ca
21 inﬂux for
activation of EC-coupling, presumably by CICR (Garcia
et al., 1994). In contrast to the two muscle isoforms a1S and
a1C, the neuronal non-L-type a1A subunit was not capable of
restoring EC-coupling in dysgenic myotubes, although a1A
generated sizable Ca21 currents (Adams et al., 1994; Flucher
et al., 2000). Here we expressed a1S, a1C, a1A, and for the
ﬁrst time the L-type Ca21 channel a1 subunit isoform a1D in
dysgenic myotubes to compare their current properties and
targeting characteristics with their ability to restore EC-
coupling.
GFP-a1D is targeted into triads of
dysgenic myotubes
Immunoﬂuorescence analysis (Fig. 1) shows that a fusion
protein of GFP attached to the N-terminus of a1D (GFP-a1D)
is efﬁciently expressed in myotubes of the dysgenic cell line
GLT and is distributed in a clustered pattern. Double labeling
of GFP-a1D and RyR1 demonstrated that GFP-a1D clusters
were co-localized with clusters of RyR1, thus identifying the
clusters as t-tubule/SR or plasma membrane/SR junctions, all
of which will from here on be called triads. GFP-a1D/RyR1
coclustering was found in 62% of 454 analyzed GFP-a1D-
expressing myotubes, which was similar to the degree of
clustering obtained with the native a1S or with a1C (see also
Fig. 4 C). Myotubes in which GFP-a1D was expressed in
a nonclustered pattern typically showed ER/SR labeling (not
shown), presumably because these myotubes were still very
immature or due to unbalanced expression of the heterolo-
gous channel and endogenous muscle proteins (Flucher et al.,
1994). Localizing GFP-a1D (Fig. 1, green) in clusters co-
incident with the RyR (Fig. 1, red ), makes a1D the third
member of the L-type Ca21 channel family that, when
expressed in skeletal muscle cells, is targeted into triads.
GFP-a1D restores Ca
21 currents
in dysgenic myotubes
Whole-cell patch-clamp measurements of dysgenic myo-
tubes expressing GFP-a1D revealed Ca
21 currents with
properties distinct from those of GFP-tagged skeletal and
cardiac a1 subunits (Fig. 2). Myotubes were selected for elec-
trophysiological analysis based on the GFP ﬂuorescence.
Ca21 currents in response to depolarizing steps from a hold-
ing potential of 80 mV to voltages between 40 and 180
mV in 10 mM extracellular Ca21 were recorded and used
to calculate the current-to-voltage (I/V) relationship of GFP-
a1D. Representative current traces for the three a1 subunit
isoforms are shown in Fig. 2 C. Comparing the average I/V
curves of GFP-a1D currents to those of GFP-a1S and GFP-
a1C expressed in dysgenic myotubes (Fig. 2 A) shows that the
FIGURE 2 Current properties of GFP-a1D expressed in dysgenic myo-
tubes compared to those of GFP-a1S and GFP-a1C. (A) Voltage dependence
of peak Ca21 current densities (pA/pF; mean6 SE) of GFP-a1D (n; n¼ 42),
GFP-a1S (; n ¼ 33), and GFP-a1C (d; n ¼ 28). Maximal current density of
GFP-a1D is similar to that of GFP-a1S and about four times lower than that
of GFP-a1C. (B) Normalized I/V curves show that GFP-a1D activates at 13
mV more negative potentials than GFP-a1C and at 37 mV more negative
potentials than GFP-a1S (for values of half maximal activation, see Table 1).
(C) Representative whole-cell current recordings of GFP-a1D, GFP-a1S, and
GFP-a1C expressed in dysgenic myotubes. Cells were held at 80 mV and
after a prepulse to inactivate low-voltage activated currents test pulses to
increasing voltages from 40 to 180 mV were applied; currents were
recorded in 10 mM Ca21. GFP-a1D activates faster than GFP-a1S.
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average maximal current density of GFP-a1D is 3.7 6 0.4
pA/pF, which is close to the value obtained with GFP-a1S
but signiﬁcantly lower (P\0.01) than the average current
density of GFP-a1C (Table 1). Furthermore, GFP-a1D acti-
tes at more negative potentials than the two other a1 subunits.
The point of half-maximal activation for GFP-a1D is ;13
mV more negative than that of GFP-a1C and 37 mV more
negative than that of GFP-a1S (Table 1). The distinct acti-
vation characteristics can be best appreciated when the I/V
curves are normalized for maximal amplitudes (Fig. 2 B).
This analysis demonstrates that GFP-a1D is functionally ex-
pressed in dysgenic myotubes and that its activation char-
acteristics resemble those reported for a1D in native cells
and for GFP-a1D in a nonmuscle expression system (Zidanic
and Fuchs, 1995; Koschak et al., 2001).
GFP-a1D restores cardiac-type EC-coupling
in dysgenic myotubes
Next it was of interest to examine whether the small Ca21
currents generated by GFP-a1D would be sufﬁcient to stim-
ulate EC-coupling in dysgenic myotubes. This was ﬁrst
analyzed by recording intracellular Ca21 signals in response
to 1-ms current pulses passed through the recording chamber,
in myotubes loaded with the ﬂuorescent Ca21 indicator ﬂuo-
4-AM. In normal myotubes and in dysgenic myotubes
transfected with GFP-a1S or GFP-a1C, this ﬁeld stimulation
protocol has previously been shown to elicit Ca21 transients
with an all-or-none response to increasing voltages. This
characteristic identiﬁes the transients as action potential-
induced Ca21 transients (Flucher et al., 1993), which rep-
resent the most physiological parameter for assessing the
restoration of EC-coupling. However, even in cultures trans-
fected with the native GFP-a1S, action potential-induced
Ca21 transients are observed only in a subset of expressing
myotubes, presumably because excitability is achieved only
in well differentiated cultured myotubes.
Cultures transfected with GFP-a1D responded to ﬁeld
stimulation with brief Ca21 transients (Fig. 3). The transients
were characterized by a rapid upstroke that terminated ab-
ruptly, indicative of a strong voltage-dependence of both, the
activation and the deactivation of the EC-coupling mecha-
nism. The average amplitudes of the transients reached a
(DF/F)max of 0.46 6 0.04, which was not signiﬁcantly
different from the amplitudes recorded with GFP-a1C or
GFP-a1S (Table 2). The speed of the upstroke and the decay
of the transients were similar between GFP-a1D and GFP-
a1C; however, the average values obtained with these
channel isoforms were signiﬁcantly slower than those of
GFP-a1S. Unless the expression of nonskeletal channels
adversely affects the overall differentiation of the myotubes,
TABLE 1 Properties of Ca21 currents and Ca21 transients recorded in reconstituted dysgenic myotubes with combined
patch-clamp and ﬂuo-4 Ca21 measurements
a1-subunit Current density (pA/pF) Gmax (nS/nF) V1/2 (mV) k (mV) (DF/F)max
a1D 3.7 6 0.4 (42)** 51.3 6 5.3 0.6 6 1.2 6.7 6 0.3 0.27 6 0.03 *** (9)
a1S 3.1 6 0.3 (33)** 112.9 6 6.8 36.0 6 1.4 7.5 6 0.3 0.96 6 0.09 (34) ***
a1C 14.1 6 1.1** (28)* 236.2 6 20.2 12.2 6 1.6 6.2 6 0.4 0.30 6 0.03 *** (10)
CSk53 22.3 6 2.2*** (35) 177.7 6 18.0 5.9 6 1.7 5.8 6 0.5 0.41 6 0.03 *** (18)
a1A 24.1 6 4.5*** (18) 264.7 6 55.9 6.0 6 1.2 1.0 6 0.2 0.50 6 0.12 ** (12)*
Entries correspond to mean 6 SE; numbers of cells are given in parentheses.
Signiﬁcance (*** P\0.001; ** P\0.01) is given in relation to a1S.
(DF/F)max values other than that of a1S are not signiﬁcantly different from one another.
FIGURE 3 Restoration of action potential-induced Ca21 transients by
GFP-a1D in dysgenic myotubes. Field stimulation at low frequency (30 V,
1 ms, 0.3 Hz/0.5 Hz) evoked rapid Ca21 transients in myotubes expressing
GFP-a1D, GFP-a1C, or GFP-a1S. Bath application of 0.5 mM Cd
21/0.1 mM
La31 immediately stopped the activation of transients in myotubes expres-
sing GFP-a1D (A) and GFP-a1C (B), indicating that the transients were
dependent on Ca21 inﬂux through the L-type channels. Addition of 6 mM
caffeine (A, right trace) triggered a strong Ca21 transient, proving that SR
Ca21 release was still functional during the Cd21/La31 block. (C) Persistent
Ca21 transients after addition of Cd21/La31 in myotubes expressing GFP-
a1S characterizes skeletal-type EC-coupling, which is independent of Ca
21
inﬂux. In contrast, GFP-a1D restored action potential-induced Ca
21 tran-
sients with cardiac characteristics. Marks underneath the traces indicate the
approximate times of stimulation; bars indicate periods of Cd21/La31 and
caffeine application.
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for which there is no independent evidence based on the
morphology of the myotubes and on the expression of
proteins seen with immunocytochemistry, this difference in
the time course of the transients probably reﬂects the
different modes of EC-coupling (see below). But most
important, despite the differences observed in the whole-cell
current properties (Fig. 2), time-to-peak, amplitudes, and
time constant of the decline of the Ca21 transients were not
signiﬁcantly different (P[0.05) between GFP-a1D and
GFP-a1C (Table 2).
When Ca21 currents were blocked by the addition of 0.5
mM Cd21/0.1 mM La31 to the bath solution while con-
tinuously stimulating, the action potential-induced Ca21
transients in GFP-a1D-transfected myotubes ceased imme-
diately (Fig. 3 A). This dependence of the Ca21 transients on
Ca21 inﬂux was similarly observed with GFP-a1C (Fig. 3 B)
and is the hallmark of cardiac-type EC-coupling. In contrast,
because skeletal EC-coupling is independent of Ca21 inﬂux,
blocking Ca21 currents with Cd21/La31 in myotubes trans-
fected with GFP-a1S did not stop action potential-induced
Ca21 transients (Fig. 3 C). To make sure that the inhibition
of Ca21 transients in myotubes expressing GFP-a1D was
indeed due to blocking the activation mechanism, SR Ca21
release was tested by the application of 6 mM caffeine
immediately after a blocking experiment. The strong Ca21
release induced by caffeine (Fig. 3 A, right trace) showed
that the failing response to ﬁeld stimulation in Cd21/La31
was not due to depletion of the SR or other effects on the
release apparatus. Thus, GFP-a1D restored cardiac-type EC-
coupling in dysgenic myotubes.
Restoration of cardiac-type EC-coupling
depends on triad targeting but not on
the magnitude of the current density
In the ﬁeld stimulation experiments GFP-a1D was as efﬁcient
as GFP-a1C in restoring action potential-induced Ca
21
transients in dysgenic myotubes. In Fig. 4 A we compare the
frequencies at which action potential-induced Ca21 tran-
sients were observed in cultures transfected with GFP-a1D,
GFP-a1C, GFP-a1A, and GFP-a1S. The number of respond-
ing cells in cultures transfected with GFP-a1D was not
signiﬁcantly different from those of GFP-a1C and GFP-a1S.
As previously shown (Flucher et al., 2000), GFP-a1A very
rarely produced action potential-induced Ca21 transients,
probably due to the fact that this channel is not targeted into
the triads. Out of six culture dishes transfected with GFP-
a1A, only a single myotube in one dish responded with an
action potential-induced Ca21 transient; therefore, the bar is
not visible at this scale (Fig. 4 A). Comparing the capability
of each of these channel isoforms to restore EC-coupling
with the average densities of their Ca21 currents shows no
correlation of the two parameters (cf. Fig. 4, A and B). For
GFP-a1S, which directly activates SR Ca
21 release, such
a correlation would not have been expected. However, for
the constructs which elicit cardiac-type EC-coupling—pre-
sumably by CICR—a correlation of current density and their
ability to activate action potential-induced Ca21 transients
was to be expected. Most interestingly, GFP-a1D, with a
current density of less than a third of that of GFP-a1C,
activated EC-coupling just as efﬁciently as the cardiac
TABLE 2 Properties of action potential-induced Ca21
transients recorded in reconstituted dysgenic myotubes
with ﬂuo-4 Ca21 measurements
a1-
subunit
Time to
peak (s) (DF/F)max
Decay time
constant t (s) N
a1S 0.068 6 0.010 0.65 6 0.09 0.255 6 0.019 26
a1D 0.370 6 0.057 *** 0.46 6 0.04 1.408 6 0.170 *** 9
a1C 0.257 6 0.030 *** 0.55 6 0.10 1.113 6 0.103 *** 18
Entries correspond to mean 6 SE. Signiﬁcance (*** P\0.001) is given in
relation to a1S; values of a1D and a1C are not signiﬁcantly different from
each other (P[0.05).
FIGURE 4 The ability of Ca21 channel isoforms to restore EC-coupling
compared to their current densities and targeting properties. (A) Myotubes
responding to ﬁeld stimulation with Ca21 transients (see Fig. 3) were counted
in cultures transfected with GFP-a1D, GFP-a1C, GFP-a1A, and GFP-a1S.
Counts from seven experiments are expressed in percent (mean 6 SE) with
the values of GFP-a1D normalized to 100%. All three L-type channels (GFP-
a1D, GFP-a1C, GFP-a1S) restored EC-coupling with similar efﬁciency,
whereas with GFP-a1A only a single responding cell was observed. (B)
Average peak current densities shown for the same channel isoforms as
above (see also Table 1). Although the nonskeletal a1 isoforms activate
action potential-induced Ca21 transients by CICR, no correlation of current
density and restoration of EC-coupling exists (cf. A and B). (C) Fraction of
myotubes in which the channel isoforms were targeted into the triads (see
Fig. 1). The triad targeting properties of the Ca21 channel isoforms exactly
correspond to their ability to restore EC-coupling (cf. A and C).
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channel. In contrast to current density, restoration of EC-
coupling correlated very well with the triad targeting pro-
perties of the individual channel isoforms (cf. Fig. 4, A and
C). Those constructs which are targeted into the triads (GFP-
a1S, GFP-a1C, GFP-a1D) all activated EC-coupling with
similar efﬁciency. However GFP-a1A, which generated the
largest current density of all examined channel isoforms (see
also Table 1) but is not targeted into triads, hardly ever
activated action potential-induced Ca21 transients in dys-
genic myotubes. Thus, for the activation of cardiac-type EC-
coupling, the spatial arrangement of the Ca21 channels
opposite the RyR appears to be more important than the pure
size of the Ca21 currents.
Ca21 transients activated by GFP-a1C and
GFP-a1D are qualitatively and quantitatively
different from those activated by GFP-a1S
To further characterize the dependence of cardiac-type EC-
coupling on Ca21 currents we performed combined patch-
clamp and ﬂuo-4 Ca21 recording experiments in dysgenic
myotubes expressing different a1 subunit isoforms. This ap-
proach enables us to simultaneously monitor the whole-cell
Ca21 inﬂux and intracellular Ca21 transients in the same
myotubes, and it allows us to analyze the voltage-depen-
dence of Ca21 transients. But these experiments differ from
the analysis of action potential-induced Ca21 transients in
several important aspects: 1), Sampling—whereas with ﬁeld
stimulation we see and record only those myotubes that
have achieved excitability and a good degree of EC-coupling
(probably the peak of the population of expressing cells),
with the patch-clamp approach we get a random sample of
differently well developed and expressing myotubes; 2),
Stimulation—instead of a 1-ms extracellular current pulse,
which stimulates an action potential lasting only a few milli-
seconds, in the patch-clamp experiments we depolarize the
cells for 200 ms giving rise to unnaturally long periods of
Ca21 inﬂux; and 3), Intracellular milieu—while the myotube
is being loaded with the Ca21 indicator through the patch
pipette, the cells are dialyzed and Ca21 buffers and the entire
intracellular milieu are altered. Thus, in this set of experi-
ments we trade in better control and quantitative analysis for
less physiological conditions. This is reﬂected in the shape of
the Ca21 transients in response to the 200-ms depolarization
(Fig. 5 C), which does not resemble that of action potential-
induced Ca21 transients (Fig. 3).
Nevertheless, important functional characteristics of the
transients, like the skeletal- and cardiac-type activation of
EC-coupling, can be distinguished in the voltage-depen-
dence curves of Ca21 transients (Garcia et al., 1994). The
amplitudes of Ca21 transients stimulated by GFP-a1C mirror
those of the Ca21 currents over a wide voltage range (Figs. 5,
A and B). In contrast, with GFP-a1S Ca
21 transients activate
at more negative potentials as the Ca21 currents and stay
fully activated at voltages near the reversal potential where
currents decline. As expected from the dependence of action
potential-induced Ca21 transients on Ca21 inﬂux shown in
Fig. 3, the voltage-dependence curves of Ca21 transients in
myotubes expressing GFP-a1D showed the cardiac charac-
teristics (Fig. 5 A). With this construct the Ca21 transients
activated in parallel with the currents at more negative
potentials than those of GFP-a1C and declined at voltages
above120 mV. Interestingly, the maximal amplitudes of the
transients for GFP-a1D and GFP-a1C were not signiﬁcantly
different (P[0.05) despite the more than threefold differ-
ence in current densities (Fig. 5; Table 1). This suggests that
currents of both channels reach the activation threshold of
CICR and trigger equal amounts of Ca21 release. However,
the maximal amplitudes of the Ca21 transients activated by
GFP-a1D or GFP-a1C were much lower than that activated
by GFP-a1S. This indicates that the native channel either
activates a larger Ca21 pool or activates SR Ca21 release
more efﬁciently than the two nonskeletal channel isoforms.
Unexpectedly, also GFP-a1A, which in the ﬁeld stimula-
tion experiments restored action potential-induced Ca21
transients very rarely (Fig.4 A), frequently produced cardiac-
type Ca21 transients in the combined patch-clamp/ﬂuo-4
Ca21 recording experiments. Apparently the mechanism that
limited activation of cardiac-type EC-coupling in response
to action potential-induced Ca21 transients to the correctly
targeted channel isoforms broke down under the conditions
of the patch-clamp experiments. But even in this case, the
average maximal amplitudes of Ca21 transients were similar
to those of GFP-a1C and GFP-a1D (Fig. 5). Whereas the
transient-to-voltage relationship for GFP-a1A is somewhat
higher than that of GFP-a1C and GFP-a1D (Table 1), this
difference is not statistically signiﬁcant (P[0.05) and
mainly reﬂects a single recording with an exceptionally
high current and transient. If this recording is excluded from
the analysis, the transients of GFP-a1A are also in the exact
same range as GFP-a1D and GFP-a1C (dotted curve in Fig. 5
A). At this point we have no explanation for the occurrence
of such exceptionally strong responders. However, one needs
to remember that also in the ﬁeld stimulation experiments
occasional responders were observed with GFP-a1A (see
above; Adams et al., 1994; Flucher et al., 2000).
Analysis of the combined patch-clamp/ﬂuo-4 Ca21
recording experiments revealed striking differences be-
tween the skeletal and nonskeletal a1 subunits expressed
in dysgenic myotubes. Plotting the amplitudes of the Ca21
transients versus the peak current densities for all individual
experiments (Fig. 5 D) shows that dysgenic myotubes
reconstituted with GFP-a1S produce Ca
21 transients of
greatly variable size (DF/F values up to 2.60) with no cor-
relation to current densities. Ca21 transients are observed
even in myotubes with no detectable currents, and some of
the myotubes with the highest current densities showed very
small transients. In contrast, GFP-a1C and GFP-a1D display
a completely different picture. Data points of both channels
spread out over a wide range of current densities but within
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a relatively narrow window of Ca21 transient amplitudes
(DF/F values between 0.15 and 0.42). The maximal transient
amplitudes of both nonskeletal channel isoforms do not
reach those of the skeletal GFP-a1S.
Furthermore, a fraction of GFP-a1C- and GFP-a1D-
expressing myotubes showed Ca21 currents but no detect-
able Ca21 transient (33% and 64% of myotubes expressing
GFP-a1C and GFP-a1D, respectively). This was never the
case with GFP-a1S. In Fig. 5 E a second set of I/V curves is
shown for GFP-a1C and GFP-a1D. In addition to the I/V
curve of those myotubes responding with both currents and
transients (same as in Fig. 5 B), I/V curves were calculated
from those recordings, in which Ca21 currents were
not accompanied with Ca21 transients. For both channel
isoforms the currents not associated with Ca21 transients
were signiﬁcantly smaller (a1D: P¼0.0001; a1C: P¼0.0180)
than those associated with transients. Thus, in both cases the
larger currents activated transients whereas the smaller
currents did not. This could be interpreted as the existence
of a threshold for triggering the Ca21 signal. However, the
whole-cell current densities necessary to activate Ca21
transients differed greatly between the two channel isoforms.
The amplitudes of Ca21 currents of GFP-a1D that were
associated with Ca21 transients were almost identical to
those of GFP-a1C that were not associated with transients
(Fig. 5 E). Thus, whereas current amplitudes matter for the
activation of Ca21 release in skeletal myotubes, the absolute
values of whole-cell current densities do not reliably describe
the activation threshold in the triad.
The two distinct groups of Ca21 transient
amplitudes do not depend on the skeletal
versus cardiac EC-coupling mechanisms
The data presented above show that GFP-a1C and GFP-a1D
expressed in dysgenic myotubes give rise to Ca21 transients
FIGURE 5 Simultaneous recording of whole-cell Ca21 currents and Ca21 transients in dysgenic myotubes transfected with skeletal and nonskeletal a1
subunit isoforms. (A, B) Voltage-dependence of Ca21 transients (A) and of Ca21 currents (B). Ca21 transients of GFP-a1S (n; n¼ 34) have a sigmoidal voltage
relationship that does not follow the I/V curve. Transient-to-voltage curves for GFP-a1C (d; n ¼ 10), GFP-a1D (; n ¼ 9), and GFP-a1A (; n ¼ 11) are bell-
shaped and follow their I/V curves with respect to activation properties but not with respect to amplitudes. Whereas current densities for GFP-a1D are
signiﬁcantly smaller than those of GFP-a1C (P ¼ 0.0011) or GFP-a1A (P ¼ 0.014), their maximal amplitudes of Ca21 transients are not signiﬁcantly different
from each other (P[0.05). The dotted line shows the shift in the GFP-a1A I/V curve after removing one exceptionally high recording from the analysis. But
transients of all nonskeletal isoforms are signiﬁcantly smaller (P\0.001) than that of GFP-a1S. (C) Representative examples of Ca
21 transients recorded with
ﬂuo-4 in parallel to whole-cell currents show the difference between skeletal and nonskeletal a1 isoforms. (D) A scatter plot of the maximal peak current
densities versus peak DF/F values for GFP-a1S (n), GFP-a1C (d), and GFP-a1D () shows that skeletal and nonskeletal Ca
21 signals clearly separate into two
distinct groups. Superthreshold Ca21 transients of GFP-a1C and GFP-a1D are conﬁned to a narrow window of amplitudes over a wide range of current
densities. (E) I/V curves of GFP-a1C (d) and GFP-a1D () (both the same as in B) compared to the average I/V curves of those currents for each group, which
did not evoke Ca21 transients (m, GFP-a1C, n ¼ 5;n GFP-a1D, n ¼ 16). For both channels, currents without transients were relatively smaller than those that
evoked transients, but the absolute values differed signiﬁcantly.
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with an average maximal amplitude at about one third of that
activated by GFP-a1S (Table 1). Therefore it was reason-
able to assume that the difference in skeletal versus cardiac
EC-coupling mechanisms (direct or Ca21-dependent) is
responsible for this striking difference. This hypothesis was
tested with a channel chimera, GFP-CSk53, which consists
of GFP-a1C with a 46-amino-acid sequence in the II-III
cytoplasmic loop replaced by the corresponding sequence of
a1S (Nakai et al., 1998). This sequence is sufﬁcient to confer
skeletal-type EC-coupling properties onto the cardiac
channel. Action potential-induced Ca21 transients persist
after application of Cd21/La31 to block Ca21 currents (Fig. 6
E). This observation is in agreement with earlier reports
showing that GFP-CSk53 activated EC-coupling by the
skeletal Ca21-independent mechanism (Nakai et al., 1998).
Fig. 6, A–D shows the voltage-dependence of Ca21
transients and currents of GFP-CSk53 compared to those
of GFP-a1S and GFP-a1C. Peak current densities similar to
those of GFP-a1C (Fig. 6 B; Table 1) demonstrate the normal
functional expression of the channel chimera. But surpris-
ingly, on ﬁrst sight the voltage relationship of the transients
of GFP-CSk53 resembled that of the cardiac and not of the
skeletal isoforms in both amplitude and shape (Fig. 6 A).
However, the analysis of individual recordings from the
combined patch-clamp/ﬂuo-4 Ca21 experiments showed that
the cardiac-like decline of the transients at voltages above
120 mV was preferentially seen in those recordings where
the baseline shifted upward during the duration of the
experiment. Dividing the recordings into those with baseline
shifts below and those above 10% (Fig. 6 C) revealed that
the records with little or no shift displayed the typical skel-
etal characteristics of the voltage-dependence of the Ca21
transients, i.e., no decline at higher test potentials. The same
analysis performed with the recordings of GFP-a1C showed
typical cardiac characteristics in both groups (Fig. 6 D).
Therefore, the apparent decline of the amplitudes of Ca21
transients at positive potentials was an experimental artifact
that could be avoided by excluding the data of recordings
with a baseline shift greater than 10%.
GFP-CSk53 activates Ca21 transients by the
skeletal mechanism
Nevertheless, its maximal Ca21 transient amplitudes were
similar to those of the nonskeletal a1 subunits (Fig. 6, A and
F). The average maximal amplitude of Ca21 transients for
GFP-CSk53 was 0.41 6 0.03, which is not signiﬁcantly
different from those of GFP-a1C and GFP-a1D but sig-
FIGURE 6 Comparison of the cardiac-skeletal chimera CSk53 with a1C and a1S. The voltage-dependences of Ca
21 transients (A) and of peak current
densities (B) of CSk53 (, n ¼ 18) resemble in size and shape those of GFP-a1C (d) but not those of GFP-a1S (n). The bell-shaped (cardiac-type) Ca21
transient-to-voltage curve of CSk53 is in disagreement with skeletal-type EC-coupling properties as indicated by the insensitivity of action potential-induced
Ca21 transients to Cd21/La31 block (E). (C) Dividing the CSk53 records into two groups based on the occurrence and magnitude of a ﬂuorescence baseline
shift (above and below 10%) shows that the stable recordings (baseline shift\ 10%; , n ¼7;[ 10%,¤, n ¼ 11) display a sigmoidal transient-to-voltage
relationship. (D) In contrast, the transient-to-voltage curves of a1C are bell-shaped regardless of the size of a baseline shift (baseline shift\ 10%, C, n ¼ 5;
[10%, d, n ¼ 5). Therefore, the bell-shaped appearance of the curve for CSk53 in A is due to this artifact, and the true character of the CSk53 transients is
skeletal. (F) A scatter plot of maximal peak current densities versus DF/F values emphasizes the difference between Ca21 transients of CSk53 and GFP-a1S.
Whereas current densities for CSk53 vary between 1.5 and 40 pA/pF, the amplitudes of the transients do not exceed DF/F values of 0.6.
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niﬁcantly lower than that of GFP-a1S (P\0.001; Table 1).
Thus, the difference in amplitudes of Ca21 transients
observed in myotubes transfected with GFP-a1C and GFP-
a1D on one hand, and with GFP-a1S on the other, cannot be
solely explained by the difference between the cardiac and
skeletal activation mechanisms.
Cardiac-type and skeletal-type Ca21 transients
can be individually activated in the same myotube
Finally, we wanted to exclude the possibility that the
relatively low Ca21 transients in myotubes transfected with
nonskeletal muscle a1 subunit isoforms and the chimera
CSk53 were simply due to a reduced Ca21 release capacity
of those myotubes. Therefore we examined whether the same
myotube responded with different size Ca21 transients when
activated by the native GFP-a1S or by a nonskeletal channel.
The low-voltage-activated Ca21 channel GFP-a1G (Monteil
et al., 2000) also gave rise to Ca21 transients in dysgenic
myotubes. These activated at potentials of 60 mV and
peaked at about 40 mV, both at ;40 mV more negative
potentials than transients in GFP-a1S-expressing myotubes
(Fig. 7 A). Similar to the Ca21 transients of all other ex-
amined nonskeletal a1 subunits, GFP-a1G transients reached
maximal amplitudes that were substantially smaller than
those of GFP-a1S. When coexpressed with GFP-a1S, Ca
21
transients activated by GFP-a1G could be well separated
from transients activated by the high-voltage-activated GFP-
a1S (Fig. 7 C). The transient-to-voltage curve of cotrans-
fected myotubes displayed a shoulder at 30 mV and
continued to rise at 10 mV (Fig. 7 A). Subtracting the
transient-to-voltage curve of GFP-a1G alone from that of the
cotransfection experiments eliminated the shoulder, resulting
in a curve with typical skeletal characteristics (Fig. 7 B).
Thus, we conclude that the shoulder represents
the contribution of GFP-a1G. The height of this shoulder is
near DF/F values of 0.3, which corresponds to transients ob-
served with GFP-a1C, GFP-a1D, GFP-a1A, and GFP-CSk53,
and it is only about one third of the maximal Ca21 signal
activated by GFP-a1S in the same cells at more positive
voltages. Thus, in our experiments Ca21 transients activated
by channels other than the native GFP-a1S peak at amplitudes
signiﬁcantly below that activated by GFP-a1S, even in the
same myotube.
DISCUSSION
In this study we investigated the properties of ‘‘cardiac-
type’’ EC-coupling activated in skeletal muscle cells by
reconstituting dysgenic myotubes with nonskeletal a1 sub-
unit isoforms. GFP-a1D—an L-type Ca
21 channel isoform
found in pancreatic b cells, hair cells of the cochlea, and in
the sinus node of the heart (Hell et al., 1993; Iwashima et al.,
1993; Kollmar et al., 1997; Takimoto et al., 1997)—was
targeted into the triads and restored action potential-induced
Ca21 transients as efﬁciently as GFP-a1C, even though its
whole-cell current density was much smaller. In combined
patch-clamp/ﬂuo-4 measurements, Ca21 transients activated
by GFP-a1C and GFP-a1D peaked at amplitudes signiﬁcantly
below those of the skeletal GFP-a1S. However, this dif-
ference in the size of Ca21 transients was not due to the dif-
ferent EC-coupling activation mechanisms, because CSk53,
a cardiac channel with skeletal EC-coupling characteristics,
also gave rise to transients of reduced magnitude.
GFP-a1D, together with the native a1S and the cardiac
a1C, is now the third member of the voltage-gated Ca
21
channel family that has been demonstrated to become
normally targeted into the skeletal muscle triads. Apparently
all the members of the L-type subclass so far examined
possess the triad targeting signals, whereas the neuronal, non-
L-type a1A does not (Flucher et al., 2000). We have pre-
viously shown that an important triad targeting signal resides
FIGURE 7 Cardiac-type and skeletal-type EC-coupling activated in-
dependently in the same myotube. (A) Voltage-dependence of Ca21 trans-
ients in dysgenic myotubes transfected with GFP-a1G alone (¤; n ¼ 9) and
in combination with GFP-a1S (n; n ¼ 9). The low-voltage activated Ca21
channel GFP-a1G generates cardiac-type Ca
21 transients activated at nega-
tive voltages with maximal amplitudes (DF/F) not signiﬁcantly different
from those of GFP-a1C and GFP-a1D (cf. Fig. 5). The I/V curve of cotrans-
fected myotubes displays a shoulder at negative potentials and continues to
rise at positive potentials to levels similar to those achieved with GFP-a1S
alone (; data from Fig. 5 A). Maintained transients at 180 V near the
reversal potential characterize this component as skeletal. (B) Subtraction of
the I/V curve of GFP-a1G from that of the GFP-a1G/GFP-a1S-cotransfected
myotubes results in a curve (d) resembling that of GFP-a1S (). (C) Ex-
amples of Ca21 transients and currents from a cotransfected cell depolarized
to 10 mV (left traces) and to 180 mV (right traces). Ca21-dependent
(cardiac-type) and Ca21-independent (skeletal-type) transients can be acti-
vated independently from each other in the same cell.
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in the C-terminus of a1S and can be conferred onto GFP-a1A
by replacing a short C-terminal sequence with the corre-
sponding sequence of a1S (Flucher et al., 2000). Similarly
the C-terminus of GFP-a1D was able to confer triad targeting
properties onto GFP-a1A (Flucher and Grabner, unpublished
results). Thus, triad targeting signals could be a conserved
property of the L-type Ca21 channel family. Alternatively,
since a1S, a1C, and a1D isoforms are all expressed in various
muscle tissues whereas a1A is not, the triad targeting property
could be a muscle-speciﬁc feature.
Ca21 currents generated by GFP-a1D expressed in
dysgenic myotubes showed the typical characteristics pre-
viously reported for a1D in native cells (Zidanic and Fuchs,
1995) and of GFP-a1D expressed in mammalian heterolo-
gous expression systems (Koschak et al., 2001). GFP-a1D
currents activated at 13 mV more negative potentials
compared to GFP-a1C. The current density of GFP-a1D in
dysgenic myotubes was less than one third of that of GFP-
a1C. Nevertheless, both channels restored action potential-
induced Ca21 transients in dysgenic myotubes equally well
and as efﬁciently as the native GFP-a1S. The fact that these
Ca21 transients were blocked by Cd21/La31 demonstrated
that the mechanism by which GFP-a1D activated action
potential-induced Ca21 transients was CICR, with the trigger
Ca21 provided by the L-type Ca21 current. Therefore it was
surprising that the considerable difference in the size of the
currents of GFP-a1D and GFP-a1C was not reﬂected in the
size of the transients or in the rate at which action potential-
induced Ca21 transients were observed. Thus, activation of
CICR is not strongly dependent on the total inﬂux of Ca21
manifested in the whole-cell current densities. This conclu-
sion is further supported by data on a1A collected by us and
others (Adams et al., 1994; Flucher et al., 2000; and present
study). While a1A expressed in dysgenic myotubes produces
high current densities the size of GFP-a1C or larger, it
restores contractions or action potential-induced Ca21
transients very rarely.
Whereas the ability of the examined a1 subunits to trigger
Ca21 transients does not correlate with the magnitude of their
Ca21 currents, it correlates well with their triad targeting
properties. All channel isoforms that are efﬁciently targeted
into the triads (GFP-a1S, GFP-a1C, GFP-a1D) also restore
action potential-induced Ca21 transients. On the other hand,
GFP-a1A fails to do either. This suggests that activation of
EC-coupling by CICR is dependent on local Ca21 concen-
trations achieved in the restricted space of the triad in the
moment of depolarization by an action potential. In the triad,
even the small GFP-a1D currents—which are of similar size
as those of a1S—attain the concentration necessary for
activating SR Ca21 release. However, the Ca21 activation
threshold of Ca21 release is not reached during ﬁvefold
larger Ca21 currents generated by the nontargeted GFP-a1A
channel isoform. A local activation mechanism for CICR
is also consistent with the observation that the termination
of the Ca21 release during action potential-induced Ca21
transients is under the tight control of the membrane po-
tential. At least in the dysgenic system, CICR is not a re-
generative process that is self-sustained by Ca21 released
through the RyRs alone. In that case transients would be
expected to continue to rise after repolarization and the
deactivation of voltage-gated Ca21 channels. On the con-
trary, the abrupt termination of the transients upon repolari-
zation argues that the sustenance of the CICR requires the
continued inﬂux of Ca21 through a voltage-gated channel.
This tight control of Ca21 activation of the Ca21 release
channels by voltage-gated Ca21 currents in dysgenic myo-
tubes reconstituted with GFP-a1C or GFP-a1D is reminiscent
of EC coupling in cardiac myocytes (Cannell et al., 1987;
Stern et al., 1999; Bers, 2000) and can only be envisioned in
the restricted space of the triad junction, where a1C or a1D
come within nanometers of the Ca21 release channel (Rios
and Stern, 1997).
A role of local Ca21 gradients in the activation of CICR in
skeletal myotubes is further corroborated by the observation
that the lower limits of current densities required for triggering
Ca21 transients differ between GFP-a1C and GFP-a1D. In
both cases failure of activation of Ca21 transients was
preferentially observed in myotubes with low current den-
sities, whereas the myotubes with higher current densities
usually produced Ca21 transients. However, the current den-
sity required for the activation of Ca21 transients was not
constant. It varied between individual myotubes, and it
was clearly different between GFP-a1C and GFP-a1D. The
existence of a threshold of current density below which no
Ca21 release would be stimulated is expected for CICR. But
this threshold should be the same in myotubes expressing
GFP-a1C and GFP-a1D. Thus, we have to conclude that the
whole-cell current densities only incompletely reﬂected
the actual Ca21 concentration at the activation site. Either
the geometry of the channels in the triad is such that the
spatiotemporal Ca21 gradients required for Ca21 activation of
the RyR are similar for GFP-a1C and GFP-a1D even though
their channel properties differ or, alternatively, the fractions of
channels inside and outside the triad might differ for the two
a1 isoforms, so that there is no linear relationship between
whole-cell current densities and current densities in the triads.
GFP-a1A, which is not targeted into triads and usually
fails to trigger action potential-induced Ca21 transients,
generated Ca21 transients in the combined patch-clamp and
ﬂuo-4 Ca21 recording experiments. On ﬁrst sight, this result
appears to contradict the hypothesis that triggering cardiac-
type EC-coupling by CICR depends on the co-localization of
the t-tubular and SR Ca21 channels in the triads. However, if
activation of CICR in the triads depends on local Ca21
gradients, these could easily break down during the 200-ms
depolarization of the patch-clamp experiments. During
a brief action potential locally high Ca21 concentrations
near the mouth of a channel may activate SR Ca21 release in
the case of channels concentrated in the triad junction,
whereas similarly high Ca21 concentrations generated by
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a1A channels diffusely located outside the triads may
dissipate in the highly buffered cytoplasm before reaching
the RyRs in the triad. However, during continued activation
over the period of 200 ms, Ca21 entering the myotube
through a1A may ﬂood the cell to a degree that spatial
gradients can no longer be maintained and CICR is triggered
even by a channel positioned outside the triad. Interfering
with the Ca21 buffering milieu in the patched myotubes may
further contribute to this inconsistent behavior under the
different experimental conditions. The different shapes of
Ca21 transients produced by the ﬁeld stimulation and in the
combined patch-clamp recordings support this explanation
(see also Garcia et al., 1994). The fact that in these ex-
periments Ca21 transients do not decline immediately after
repolarization suggests that in contrast to action potential-
induced Ca21 transients, CICR stimulated by long depolari-
zation contains a regenerative component, which sustains
Ca21 release even in the absence of inﬂux. Also the slow
decline of the Ca21 transients indicates that the cytoplasmic
Ca21 buffering capacity has been exceeded under these ex-
perimental conditions. Applying shorter test pulses (10 ms)
partially reversed this problem, and Ca21 transients looked
more like those of the action potential-induced Ca21 tran-
sients (not shown). However, analyzing the voltage-de-
pendence of current and transient activation and a reliable
comparison of current densities of channels with different
activation kinetics necessitated long depolarization. There-
fore, even though analysis of Ca21 signals under voltage-
clamp control is common practice and has contributed
signiﬁcantly to our current understanding of EC-coupling
(e.g., Baylor et al., 1983; Brum et al., 1987; Melzer et al.,
1984; Beurg et al., 1997; Dietze et al., 1998; Jurkat-Rott
et al., 1998; Grabner et al., 1999; Wilkens et al., 2001), it has
to be kept in mind that spatiotemporal Ca21 gradients, which
appear to be critical for activation of CICR under physio-
logical conditions, probably break down during prolonged
patch-clamp recordings.
A trivial alternative explanation for the different size,
shape, and behavior of Ca21 transients obtained with patch-
clamp stimulation would be that the transients recorded from
nonskeletal Ca21 channels in the patch-clamp mode are
not CICR at all, but simply reﬂect the Ca21 inﬂux through
these channels. This would explain the reduced amplitude
compared to that of the skeletal transients as well as
the fact that GFP-a1A, which failed to restore action poten-
tial-induced Ca21 transients, generates a Ca21 signal under
patch-clamp conditions. Attempts to test this possibility by
pharmacologically isolating a possible Ca21 inﬂux signal
from that of CICR did not resolve the issue either, because
even concentrations between 10 mM and 40 mM ryanodine
(Lipp et al., 2002) or 10 mM and 160 mM ruthenium red (Xu
et al., 1999) in the patch pipette did not completely block
Ca21 release in control myotubes transfected with GFP-a1S.
However, important evidence from this and previous studies
(Tanabe et al., 1990; Garcia et al., 1994; Garcia and Beam,
1994) argues against the possibility that these Ca21 transients
arise exclusively from Ca21 inﬂux: ﬁrst, the poor correlation
of current densities with the occurrence of associated Ca21
transients in individual myotubes; i.e., myotubes with current
densities as small as 3 pA/pF showed transients whereas
other myotubes with much larger currents showed no mea-
surable transients (Fig. 5 D) (see also Garcia et al., 1994);
second, the poor correlation of current densities with the
amplitudes of Ca21 transient for GFP-a1C and GFP-a1D, i.e.,
whereas their current densities differed by almost threefold,
GFP-a1C and GFP-a1D produced Ca
21 transients of similar
magnitude (Fig. 5, A and B); and ﬁnally, Ca21 transients
triggered by the cardiac-skeletal chimera GFP-CSk53 were
not signiﬁcantly larger than those of GFP-a1C, as would be
expected from a construct that triggers skeletal-type Ca21
release in addition to a ﬂuo-4 signal reﬂecting pure Ca21
inﬂux. If we had merely recorded the inﬂux of Ca21, the
magnitude of the Ca21 transients should be highly correlated
to the underlying currents. On the contrary, the behavior
of the observed Ca21 transients is consistent with a CICR
mechanism that depends not only on the size of the Ca21
inﬂux but also on its local density.
Comparing the voltage-dependence of the Ca21 currents
with that of the Ca21 transients revealed important proper-
ties of CICR in skeletal myotubes. For the nonskeletal chan-
nels, the voltage-dependence of the Ca21 transients faithfully
followed that of the current density, resulting in the bell-
shaped curve typical for cardiac-type EC-coupling (Tanabe
et al., 1990). Moreover, differences in the voltage-de-
pendence of the currents, like the left-shifted activation of
GFP-a1D, can similarly be observed for the transients. This
strict correlation of current amplitudes and transient am-
plitudes at different voltages clearly indicates that CICR is
not simply an all-or-none mechanism. Smaller currents give
rise to smaller transients and larger currents give rise to
larger transients. Thus, CICR in individual skeletal myotubes
functions as a graded ampliﬁcation system in which Ca21
entering the myotube through the voltage-gated channels
is proportionally ampliﬁed by Ca21 released from the SR.
Nevertheless, considerable differences in current densities
between individual cells and the differences in the average
current densities of GFP-a1C and GFP-a1D are not reﬂected
in the maximal amplitudes of the transients. These are very
similar in all myotubes expressing nonskeletal a1 subunits,
and they peak at a level way below the maximal capacity of
SR Ca21 release. Thus, it seems that irrespective of their
different current properties, GFP-a1C, GFP-a1D, GFP-a1A,
and GFP-a1G activate the same maximal amount of Ca
21
release in the combined patch-clamp/ﬂuo-4 recordings.
This reduced maximum of Ca21 release achieved by the
nonskeletal channels is, however, not due to a limited release
capacity of the EC-coupling apparatus. Ca21 transients ac-
tivated by GFP-a1S were on average three times larger than
those of nonskeletal channels. This observation is consistent
with similar differences seen in an earlier report comparing
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a1S and a1C expressed in myotubes of dysgenic primary
cultures (Garcia et al., 1994). But perhaps myotubes reconsti-
tuted with the skeletal GFP-a1S channel differentiate better
than myotubes expressing the heterologous channel isoforms
and therefore generate more robust Ca21 transients? How-
ever, even on a single myotube level we observed that non-
skeletal Ca21 channels released only a fraction of the Ca21
releasable by GFP-a1S. Myotubes cotransfected with a low-
voltage-activated channel GFP-a1G and the high-voltage-acti-
vated GFP-a1S showed the typical small cardiac-type Ca
21
transients at negative voltages followed by up to ﬁvefold
larger skeletal-type transients at positive voltages. This indi-
cates that nonskeletal channels only partially activate the
Ca21 release capacity of dysgenic myotubes.
Interestingly, the cause of this differential ability to ac-
tivate Ca21 release is not, as one might think, the difference
between skeletal and cardiac-type activation of Ca21 release.
GFP-CSk53, a cardiac-based channel chimera with skeletal
EC-coupling properties (Nakai et al., 1998), also induced
small transients like those of GFP-a1C and GFP-a1D.
Apparently channel isoforms and chimeras other than a1S
activate SR Ca21 release less efﬁciently than the native
channel, and transferring skeletal EC-coupling properties
onto a cardiac-type channel is not sufﬁcient to overcome this
deﬁciency. It may well be that other properties speciﬁc to the
skeletal a1S subunit enable a1S to activate more Ca
21 release
channels or the same number more efﬁciently than non-
skeletal channels. Thus, the body of the channel—skeletal or
nonskeletal—as well as the region in the II-III loop important
for skeletal-type activation of EC-coupling seems to be
important for the magnitude of Ca21 release achieved in
reconstituted dysgenic myotubes.
The combined evidence from this and previous studies
allows drafting of the following model of the role of CICR in
skeletal muscle contraction. CICR appears to be a signiﬁcant
component of skeletal muscle EC-coupling (O’Brien et al.,
2002). To activate CICR in skeletal muscle, a threshold
concentration of Ca21 in the triads needs to be exceeded.
During the brief depolarization of an action potential, this is
achieved only by channels located in close range of the RyRs
within the triad junction, but not by Ca21 inﬂux outside the
triads. Interestingly, Ca21 currents the size of the skeletal a1S
are capable of activating CICR, whereas SR Ca21 release
through the RyRs alone cannot sustain its own further release
after repolarization. Thus, in normal EC-coupling CICR is
not regenerative but ampliﬁes the trigger Ca21 signal while
remaining under the strict control of the voltage-activated
channels. Upon long depolarization, and possibly also dur-
ing tetanic stimulation or certain pathologic conditions like
malignant hyperthermia, the strict local control of CICR
breaks down and regenerative activation of CICR in skeletal
muscle may occur. Thus, the spatial arrangement of voltage-
activated channels and SR Ca21 release channels in the triad
plays an essential part in the control of Ca21 release in
skeletal muscle EC-coupling.
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